Jack Lott
About Jack Lott
Jack Lott is the Associate Director of World Wide Patient Safety at Bristol Myers Squibb, with extensive experience in project management and risk management in the pharmaceutical industry.
Current Role at Bristol Myers Squibb
Jack Lott currently holds the position of Associate Director, World Wide Patient Safety at Bristol Myers Squibb in Summit, NJ. In this role, he co-led the global risk management strategy for Celgene’s/BMS’s first two CAR T products as well as Celgene’s first non-thalidomide analogue REMS. His responsibilities also include developing Standard Operating Procedures (SOPs) and work practices for the organization, and he has represented his department as an Enterprise Change Champion during change management processes.
Previous Role at UBC
Jack Lott worked at UBC - An Express Scripts Company as a Project Manager for REMS Programs from 2014 to 2017 in Blue Bell, PA. His experience there included involvement in the Request for Proposal (RFP), bid defense, and contracting processes. His role required coordination and management of regulatory and safety protocols for various projects.
Experience at ERT
At ERT, Jack Lott served as a Project Manager from 2010 to 2014 in Philadelphia, PA. During his tenure, he gained significant experience with both internal and external audits, and was comfortable managing roles in both the back room and front room during these audit processes. His work involved ensuring compliance with regulatory standards and optimizing project workflows.
Background in Molecular Imaging at CoreLab Partners, Inc.
Jack Lott held the position of Assistant Manager in Molecular Imaging at CoreLab Partners, Inc. from 2006 to 2010 in Princeton, NJ. This role involved managing molecular imaging projects and overseeing various aspects of imaging processes. His technical proficiency and organizational skills contributed to the success of multiple projects during his 4-year tenure.
Educational Background
Jack Lott holds a Master of Science (MS) in Biotechnology from The Johns Hopkins University, and a Bachelor of Science (BS) in Biology and Chemistry from Ramapo College of New Jersey. His educational background laid a strong foundation for his career in patient safety, project management, and risk management in the pharmaceutical and biotechnology sectors.